Legal Opinion on the First Extraordinary Shareholders' Meeting of Shanghai Xuerong Biotechnology Co., Ltd. in 2026
To: Shanghai Xuerong Biotechnology Co., Ltd.
Grandall Law Firm (Shanghai) (hereinafter referred to as "this firm") has been entrusted by Shanghai Xuerong Biotechnology Co., Ltd. (hereinafter referred to as "the company") to appoint lawyers from this firm to attend the company's first extraordinary shareholders' meeting in 2026 (hereinafter referred to as "this meeting"). This firm issues this legal opinion regarding the legality of the convening and holding procedures of the meeting, the qualifications of attendees, the qualifications of the convener, the voting procedures, and the voting results based on the provisions of the Securities Law of the People's Republic of China (hereinafter referred to as "the Securities Law"), the Company Law of the People's Republic of China (hereinafter referred to as "the Company Law"), the Rules for Shareholders' Meetings of Listed Companies (hereinafter referred to as "the Meeting Rules"), and other relevant laws, regulations, departmental rules, and normative documents.
To issue this legal opinion, this firm has reviewed the relevant matters concerning this shareholders' meeting, examined the documents deemed necessary for issuing this legal opinion, and conducted necessary verification and validation of relevant issues. This legal opinion is solely for the purpose of witnessing this shareholders' meeting and shall not be used for any other purpose. This firm agrees to announce this legal opinion together with the resolutions of this shareholders' meeting and shall bear corresponding responsibilities in accordance with the law.
This firm issues the following legal opinions in accordance with the requirements of relevant laws, regulations, and normative documents, and in accordance with the recognized business standards, ethical norms, and diligent spirit of the legal profession: